Innate Pharma S.A. IPHA
1.33 USD -0.07 (-5.00%)
At closeNov 3, 2026, 4:00 PM EST
1.38 +0.05 +3.76%
After hours · Nov 3, 4:00 PM ET
1.32 Day range 1.35
1.17 52-week range 2.71
- YTD
- -24.00%
- 1 year
- -30.00%
Ownership
Held by insiders 0.00%
Held by institutions 0.50%
Float held by institutions 0.50%
Institutions 11
Top institutional holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Optiver Holding B.v. | 0.10% | 86,788 | 182.25K | Sep 29, 2024 |
| Exchange Traded Concepts LLC | 0.09% | 77,350 | 162.43K | Sep 29, 2024 |
| Morgan Stanley | 0.05% | 43,524 | 91.40K | Sep 29, 2024 |
| Citadel Advisors Llc | 0.03% | 21,267 | 44.66K | Sep 29, 2024 |
| UBS Group AG | 0.01% | 8,408 | 17.66K | Sep 29, 2024 |
| Rhumbline Advisers | 0.00% | 205 | 430 | Sep 29, 2024 |
Top mutual fund holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| ETF Series Solutions-Range Cancer Therapeutics ETF | 0.09% | 73,688 | 154.74K | Aug 30, 2024 |
| Trust for Professional Managers-ActivePassive International Equity ETF | 0.08% | 64,826 | 136.13K | Aug 30, 2024 |
Insiders
No insider holdings on record